Bioorganic & Medicinal Chemistry Letters · 2013 · 21 citations · 21 references
MedicineMedicinal ChemistryPharmacologyCancer PharmacologyDrug DiscoveryMolecular PharmacologyEnzyme InhibitionLigand BindingTyrosine Kinase InhibitorsAbsolute Oral BioavailabilityDual-target InhibitorsMedicinal Chemistry ApplicationsMek InhibitorsOral Bioavailability OptimizationOral Drug Bioavailability
21
Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
Keith T. Flaherty, Caroline Robert, Peter Hersey et al. · New England Journal of Medicine · 2012 · 2.1K citations · Full text
Medicine, Oncology, Pharmacology +17
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
Gideon Bollag, Peter Hirth, James Tsai et al. · Nature · 2010 · 1.8K citations
Medicine, Oncology, Pharmacology +14
Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
Judith S. Sebolt–Leopold, David T. Dudley, Román Herrera et al. · Nature Medicine · 1999 · 969 citations
Medicine, Cancer Biology, Oncology +14